Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P62491
UPID:
RB11A_HUMAN
Alternative names:
YL8
Alternative UPACC:
P62491; B2R4B6; B4DT13; P24410; Q5TZN9; Q9JLX1
Background:
Ras-related protein Rab-11A, also known as YL8, plays a pivotal role in intracellular membrane trafficking. It regulates the transition between the inactive GDP-bound form and the active GTP-bound form, orchestrating vesicle formation, movement, tethering, and fusion. Rab-11A is instrumental in endocytic recycling, cytokinesis, epithelial cell polarization, and lumenogenesis. It is involved in the transport and sorting of various proteins, including CFTR, NPC1L1, and CDH1, to the plasma membrane, highlighting its critical role in cellular processes.
Therapeutic significance:
Understanding the role of Ras-related protein Rab-11A could open doors to potential therapeutic strategies.